OSU
Welcome,         Profile    Billing    Logout  
 2 Trials 
12 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Weiss, Raul
INTEGRA-D, NCT05855135: Assessment of Combined CCM and ICD Device in HFrEF

Recruiting
N/A
300
US
OPTIMIZER® Integra CCM-D System (Treatment Arm)
Impulse Dynamics
Heart Failure, Heart Failure with Reduced Ejection Fraction, Implantable Defibrillator User, CCM Therapy, Non-ischemic Cardiomyopathy, Ischemic Cardiomyopathy, Sudden Cardiac Arrest, Arrhythmias, Cardiac, Ventricular Tachycardia, Ventricular Fibrillation
06/25
12/25
ADVENT PAS, NCT06431815: ADVENT Post-Approval Study

Recruiting
N/A
220
Canada, US, RoW
FARAPULSE™ Pulsed Field Ablation System, FARAWAVE™ Pulsed Field Ablation Catheter
Boston Scientific Corporation
Paroxysmal Atrial Fibrillation
10/28
10/29
NCT03970343: Post Approval Study (PAS) of the OPTIMIZER Smart and CCM Therapy

Recruiting
N/A
620
US
OPTIMIZER Smart System
Impulse Dynamics
Heart Failure
03/26
03/26
Line, Main
LB1908-1001, NCT05539430: Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma

Recruiting
1
56
US
LB1908
Legend Biotech USA Inc
Gastric Cancer, Gastroesophageal-junction Cancer, Esophageal Cancer, Pancreatic Cancer
07/25
12/25
Esparza, Melissa
RISE 2, NCT06132893: A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

Recruiting
2/3
390
Europe, US, RoW
BHV-7000, Placebo
Biohaven Therapeutics Ltd.
Focal Epilepsy
08/25
09/25
NCT06377930: Study Evaluating the Safety and Efficacy of RAP-219 in Adult Participants With Refractory Focal Epilepsy

Recruiting
2
20
US
RAP-219
Rapport Therapeutics Inc.
Focal Onset Seizures
03/25
06/25
GenTLE, NCT06063850: AMT-260 Gene Therapy Study in Adults with Unilateral Refractory Mesial Temporal Lobe Epilepsy

Recruiting
1/2
12
US
AAV9-hSyn1-miGRIK2, AMT-260
UniQure Biopharma B.V.
Mesial Temporal Lobe Epilepsy
11/26
06/27
AUT022201, NCT05873062: Safety, Blood Levels and Effects of AUT00201 in Patients With MEAK

Completed
1
6
US
AUT00201, Placebo
Autifony Therapeutics Limited
Myoclonus Epilepsies, Progressive
05/24
05/24
NCT04770337: Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy

Recruiting
N/A
190
Europe, US
STARSTIM device, Sham Device
Neuroelectrics Corporation
Refractory Epilepsy, Focal Seizure, Seizures, Focal, Seizures, Epilepsy in Children, Epilepsy, Epilepsy, Tonic-Clonic
11/25
07/26
Wiley, Elizabeth Beth
RISE 2, NCT06132893: A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

Recruiting
2/3
390
Europe, US, RoW
BHV-7000, Placebo
Biohaven Therapeutics Ltd.
Focal Epilepsy
08/25
09/25
HEALEY ALS, NCT04297683: Platform Trial - Master Protocol

Active, not recruiting
2/3
1500
US
Zilucoplan, Verdiperstat, CNM-Au8, Pridopidine, SLS-005 Trehalose, ABBV-CLS-7262, DNL343
Merit E. Cudkowicz, MD, Massachusetts General Hospital
Amyotrophic Lateral Sclerosis
07/25
04/26
GenTLE, NCT06063850: AMT-260 Gene Therapy Study in Adults with Unilateral Refractory Mesial Temporal Lobe Epilepsy

Recruiting
1/2
12
US
AAV9-hSyn1-miGRIK2, AMT-260
UniQure Biopharma B.V.
Mesial Temporal Lobe Epilepsy
11/26
06/27

Download Options